Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Efalizumab 125mg powder and solvent for solution for injection vials |
| BNF code | 1305030A0AAAAAA |
| Virtual Therapeutic Moiety | Efalizumab |
| Abbreviated name | Efalizumab 125mg inj vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 17 Jun 2009 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Efalizumab |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 125.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.subcutaneous |
| Dose Form | |
| Formulation | Powder and solvent for solution for injection |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Efalizumab 125mg powder and solvent for solution for injection vials 1 vial | |
| Efalizumab 125mg powder and solvent for solution for injection vials 4 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.